Citations for
1IL32
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance.
Dali-Youcef N, Vix M, Costantino F, El-Saghire H, Lhermitte B, Callari C, D'Agostino J, Perretta S, Paveliu S, Gualtierotti M, Dumeny E, Oudot MA, Jaulin A, Dembélé D, Zeisel MB, Tomasetto C, Baumert TF, Doffoël M.
Hepatol Commun 3(9):1205-1220. doi: 10.1002/hep4.1396. eCollection 2019 Sep. 2019
2IL32
Interleukin 32 expression in human melanoma.
Paz H, Tsoi J, Kalbasi A, Grasso CS, McBride WH, Schaue D, Butterfield LH, Maurer DM, Ribas A, Graeber TG, Economou JS.
J Transl Med 17(1):113. doi: 10.1186/s12967-019-1862-y. 2019
3IL32
Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease.
Yang Z, Shi L, Xue Y, Zeng T, Shi Y, Lin Y, Liu L.
Clin Chim Acta 497:104-109. doi: 10.1016/j.cca.2019.07.019. Epub 2019 Jul 19. 2019
4IL32
The proinflammatory cytokine TNFα induces DNA demethylation-dependent and -independent activation of interleukin-32 expression.
Zhao Z, Lan M, Li J, Dong Q, Li X, Liu B, Li G, Wang H, Zhang Z, Zhu B.
J Biol Chem 294(17):6785-6795. doi: 10.1074/jbc.RA118.006255. Epub 2019 Mar 1. 2019
5IL32, TIMP3
IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
Yun J, Park MH, Son DJ, Nam KT, Moon DB, Ju JH, Hwang OK, Choi JS, Kim TH, Jung YS, Hwang DY, Han SB, Yoon DY, Hong JT.
Cell Death Dis 9(3):306. doi: 10.1038/s41419-018-0375-6. 2018
6IL32
Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients.
Damen MSMA, Schraa K, Tweehuysen L, den Broeder AA, Netea MG, Popa CD, Joosten LAB.
Sci Rep 8(1):14050. doi: 10.1038/s41598-018-32485-0. 2018
7IL32
Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.
Kim DH, Park ES, Lee AR, Park S, Park YK, Ahn SH, Kang HS, Won JH, Ha YN, Jae B, Kim DS, Chung WC, Song MJ, Kim KH, Park SH, Kim SH, Kim KH.
Nat Commun 9(1):3284. doi: 10.1038/s41467-018-05782-5. 2018
8IL32
Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model.
Gonnet J, Perrin H, Hutton AJ, Boccara D, Bonduelle O, Mimoun M, Atlan M, Soria A, Combadière B.
Br J Dermatol 179(1):145-153. doi: 10.1111/bjd.16721. Epub 2018 May 28. 2018
9IL32
Insights into the role of IL-32 in cancer.
Sloot YJE, Smit JW, Joosten LAB, Netea-Maier RT.
Semin Immunol 38:24-32. doi: 10.1016/j.smim.2018.03.004. Epub 2018 May 8. Review. 2018
10IL32
Overexpression of interleukin-32α promotes invasion by modulating VEGF in hepatocellular carcinoma.
Zhao WB, Wang QL, Xu YT, Xu SF, Qiu Y, Zhu F.
Oncol Rep 39(3):1155-1162. doi: 10.3892/or.2017.6162. Epub 2017 Dec 19. 2018
11IL32
Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
Int J Rheum Dis 21(12):2167-2174. doi: 10.1111/1756-185X.13072. Epub 2017 Apr 5. 2018
12IL32
Association between interleukin-32 polymorphism and multiple sclerosis.
Morsaljahan Z, Rafiei A, Valadan R, Abedini M, Pakseresht M, Khajavi R.
J Neurol Sci 379:144-150. doi: 10.1016/j.jns.2017.05.045. Epub 2017 May 23. 2017
13IL15, IL32
Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.
Gorvel L, Korenfeld D, Tung T, Klechevsky E.
J Immunol 199(4):1290-1300. doi: 10.4049/jimmunol.1601477. Epub 2017 Jul 12. 2017
14IL32
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.
Lee EJ, Kim SM, Choi B, Kim EY, Chung YH, Lee EJ, Yoo B, Lee CK, Hong S, Kim BJ, Koh JM, Kim SH, Kim YG, Chang EJ.
Sci Rep 7:40240. doi: 10.1038/srep40240. 2017
15IL32
Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.
Wang Y, Zhou B, Zhao Y, Yu X, Liu Y, Zhang L.
Dis Markers 2016:2460206. doi: 10.1155/2016/2460206. Epub 2016 Feb 29. 2016
16IL32
Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.
Heinhuis B, Plantinga TS, Semango G, Küsters B, Netea MG, Dinarello CA, Smit JWA, Netea-Maier RT, Joosten LAB.
Carcinogenesis 37(2):197-205. doi: 10.1093/carcin/bgv172. Epub 2015 Dec 17. 2016
17IL32
Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells.
Ota K, Kawaguchi M, Fujita J, Kokubu F, Huang SK, Morishima Y, Matsukura S, Kurokawa M, Ishii Y, Satoh H, Sakamoto T, Hizawa N.
Exp Lung Res 41(6):335-43. doi: 10.3109/01902148.2015.1033569. Epub 2015 Jul 7. 2015
18IL32, MMP13
Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.
Zhou Y, Hu Z, Li N, Jiang R.
Int J Mol Med 35(6):1729-33. doi: 10.3892/ijmm.2015.2159. Epub 2015 Mar 31. 2015
19IL32
IL-32 is a molecular marker of a host defense network in human tuberculosis.
Montoya D, Inkeles MS, Liu PT, Realegeno S, Teles RM, Vaidya P, Munoz MA, Schenk M, Swindell WR, Chun R, Zavala K, Hewison M, Adams JS, Horvath S, Pellegrini M, Bloom BR, Modlin RL.
Sci Transl Med 6(250):250ra114. doi: 10.1126/scitranslmed.3009546. 2014
20IL32
Interaction network mapping among IL-32 isoforms.
Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Ham SY, Park SH, Kim H, Ahn JH, Hong JT, Yoon DY.
Biochimie 101:248-51. doi: 10.1016/j.biochi.2014.01.013. Epub 2014 Jan 25. 2014
21IL32
IL-32 promotes angiogenesis.
Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF.
J Immunol 192(2):589-602. doi: 10.4049/jimmunol.1202802. Epub 2013 Dec 11. 2014
22IFNL1, IL32
Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).
Li Y, Xie J, Xu X, Liu L, Wan Y, Liu Y, Zhu C, Zhu Y.
J Biol Chem 288(29):20927-41. doi: 10.1074/jbc.M112.440115. Epub 2013 May 31. 2013
23IL32
TLR-mediated induction of proinflammatory cytokine IL-32 in corneal epithelium.
Zhang L, Che C, Lin J, Liu K, Li DQ, Zhao G.
Curr Eye Res 38(6):630-8. doi: 10.3109/02713683.2012.763102. Epub 2013 Mar 27. 2013
24IL32
Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.
Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA, Joosten LA.
J Biol Chem 287(8):5733-43. doi: 10.1074/jbc.M111.288290. Epub 2011 Dec 27. 2012
25IL32
Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.
Park MH, Song MJ, Cho MC, Moon DC, Yoon DY, Han SB, Hong JT.
Immunology 135(1):63-72. doi: 10.1111/j.1365-2567.2011.03513.x. 2012
26IL32, TNFRSF1A
Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1.
Turner-Brannen E, Choi KY, Arsenault R, El-Gabalawy H, Napper S, Mookherjee N.
J Immunol 186(12):7127-35. doi: 10.4049/jimmunol.1002306. Epub 2011 May 20. 2011
27IL32
Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB.
Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G, Shen G.
Mol Immunol 48(12-13):1573-7. doi: 10.1016/j.molimm.2011.03.012. Epub 2011 Apr 8. 2011
28IL32
The effects of IL-32 on the inflammatory activation of cultured rat primary astrocytes.
Cho KS, Park SH, Joo SH, Kim SH, Shin CY.
Biochem Biophys Res Commun 402(1):48-53. doi: 10.1016/j.bbrc.2010.09.099. Epub 2010 Oct 1. 2010
29IL32
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis.
Meyer N, Zimmermann M, Bürgler S, Bassin C, Woehrl S, Moritz K, Rhyner C, Indermitte P, Schmid-Grendelmeier P, Akdis M, Menz G, Akdis CA.
J Allergy Clin Immunol 125(4):858-865.e10. doi: 10.1016/j.jaci.2010.01.016. Epub 2010 Mar 15. 2010
30IL32
Interleukin-32 expression in the pancreas.
Nishida A, Andoh A, Inatomi O, Fujiyama Y.
J Biol Chem 284(26):17868-76. doi: 10.1074/jbc.M900368200. Epub 2009 Apr 21. 2009
31IL32
Molecular characterization of IL-32 in human endothelial cells.
Kobayashi H, Lin PC.
Cytokine 46(3):351-8. doi: 10.1016/j.cyto.2009.03.007. Epub 2009 Apr 11. 2009
32IL32
Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA, Deeg HJ.
Proc Natl Acad Sci U S A 105(8):2865-70. Epub 2008 Feb 19. 2008
33IL32
Interleukin-32 induces the differentiation of monocytes into macrophage-like cells.
Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, Dinarello CA, Kim SH.
Proc Natl Acad Sci U S A 105(9):3515-20. Epub 2008 Feb 22. 2008
34IL32
Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.
Raymond WW, Cruz AC, Caughey GH.
J Biol Chem 281(3):1489-94. Epub 2005 Nov 22. 2006
35IL32
IL-32, a proinflammatory cytokine in rheumatoid arthritis.
Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB.
Proc Natl Acad Sci U S A 103(9):3298-303. Epub 2006 Feb 21. 2006
36FMF, FMF, IL32, MEFV, OR1F2P, OR2C1, TRKPR@, ZNF174
Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3.
Centola M, et al.
Genome Res 8(11):1172-91. 1998
37IL32
Identification of a novel gene expressed in activated natural killer cells and T cells.
Dahl CA, et al.
J Immunol 148(2):597-603. 1992
38IL32
14.
Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Sloot YJE, Rabold K, Ulas T, De Graaf DM, Heinhuis B, Händler K, Schultze JL, Netea MG, Smit JWA, Joosten LAB, Netea-Maier RT loot YJE, Rabold K, Ulas T, De Graaf DM, Heinhuis B, Händler K, Schultze JL, Netea MG, Smit JWA, Joosten LAB, Netea-Maier RT.